Rating History for Genmab A/S (GMAB) by Wells Fargo
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/2/2026 | Eva Fortea Verdejo | New Coverage | Overweight (N/A) |
40.00 (N/A) |
29.44 (27.06) |
-8.08% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/2/2026 | Eva Fortea Verdejo | New Coverage | Overweight (N/A) |
40.00 (N/A) |
29.44 (27.06) |
-8.08% | Details |